The three major isoforms of AMPdeaminase ( M a ) were localized in human skeletal m d e and cultured muscle cells by immunocytochemistry. The M isoform was mainly located in Type II muscle fibers and showed a clear cross-striation.
koform was predomhmtly observed in nerve bundles and to a minor extent in smooth muscle cells and endothelial cells. The E isoform was predominantly present in smooth muscle cells, and to a lesser extent in Type I muscle fibers and nerve bundles. In quadriceps musde of patients with myoadenylate deaminase deficienq, no immMOst?ining for eroduction Adenosine monophosphate deaminase (AMPda; EC 3.5.4.6.) catalyzes the irreversible hydrolytic deamination of AMP to IMP and ammonia. AMPda plays a role in purine nucleotide interconversion and is one of the three enzymes involved in the purine nudeotide cycle (Van den Berghe et al., 1992; Tullson and Terjung, 1991; henstein, 1972 , 1990 .
In muscle, this cycle is involved in (a) the maintenance of the high ATPADP ratio by pulling the myokinase reaction (2 ADP ATP + AMP) towards ATP by AMP removal, (b) limiting the degradation of adenine nucleotides to purine bases, (c) replenishment of citric acid cycle intermediates leading to an enhancement of aerobic energy production, and (d) deamination of amino acids for oxidative metabolism. Two other proposed functions, regulation of phosphofructokinase activity by NH4' concentration and regulation of phosphorylase b activity by the IMP concentration, are less likely (Van den Berghe et al., 1992; Tullson and Terjung, 1991) .
In human, at least four isofonns of the tetrameric AMPda exist: the M (muscle), the L (liver), and the El and E2 (erythrocyte) isoforrns (Ogasawara et al., 1982) . The M, L, and E isoforms differ from each other in kinetic, regulatory, immunological, and chromatographic properties (Ogasawara et al., 1982) . In rat these isozymes are named A, B, and C isoforms, respectively (Thompson et al., 1992) . AMPda is a multigene family (Morisaki et al., 1990) . The M isoform, the predominant form in skeletal muscle, is encoded by the AMPDl gene , the L isoform by the AMPD2 gene (Bausch-Jurken et al., 1992) and the El and E2 isoforms, presumably through altemative splicing, by the AMPD3 gene (Mahnke-Zizelman and . Altemative splicing in the AMPDl and AMPD2 genes predicts multiple forms for the M and L isoforms as well (Morisaki et al., 1993; Van den Bergh and Sabina, 1993) .
Biochemical analysis of AMPda isoforms indicates a restricted distribution in human tissues (Ogasawara et al., 1982) . Recently, the distribution of the major isoforms of AMPda has been documented for rat skeletal muscle (Thompson et al., 1992) . We report here on the disuibution of AMPda isofonns in human skeletal muscle and cultured muscle cells. We found a salient occurrence of the M isoform in the postsynaptic part of the neuromuscular junction.
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Materials and Methods
Skeletal Muscle Tissue. Human diaphragm was obtained at autopsy within 6 hr after death. Biopsies of human m. quadriceps were obtained from patients who underwent surgery for diagnostic purposes. On examination, no histological. histochemical, or biochemical abnormalities were present. Biopsies of m. quadriceps of four patients with primary (congenital) AMPda (myoadenylate deaminase) dcficicncy were also studied. These patients (ages 11-18 years) have been described in detail (Sinkcler et al., 1988 , Patients 11112, 2112 , 2113 . AMPda activity in muscle biopsies from these patients is less than 1% of control values. mononuclear cells. obtained after dissociation of biopsy specimens of m. rectus abdominis and m. quadriceps, were plated in tissue culture dishes in Dulbccco's modified Eagle's medium (DMEM) containing 20% fctal calf serum and 2% chicken embryo extract. After 1 day, non-adhering cells and cell debris were washed away. Two combinations of proliferation and differentiation media were then applied: (1) cells were grown to confluency in 20% fetal calf setum/2% chicken embryo extract and allowed to differentiate in 10% horscscmml21 chickenembryoemract. or(b)cellsweregrown in 10% brain extract/4% Ultroscr G (a ddined medium) and differentiated in 10% brain acuact/0.4% Ultroscr G. The latter combination rcsults in differentiated myotubes with a higher maturation grade as judged by biochemical and morphological criteria (Van Kuppcwlt et al.. 1992; Bcndcn et al.. 1991) . Anti-AMPda Antibodies. Rabbit antihMPda M antiserum was raised against purified AMPda M from human skeletal muscle and its monospecificity has been described (Fishbein et al., 1980a (Fishbein et al., .1993 . Rabbit antihMPda L antiserum was raised against AMPda from rat brain (fraction IV) and in human tissue is specific for the L isoform (Ogasawara et al., 1974) . Rabbit anti-AMPda E antiserum was raised against AMPda El from human erythrocytes and its specificity has been described; the serum shows crossreactivity only with isoform AMPda E2, a minor isoform in erythrocytes that is closely related to the El isoform (Ogasawara et al., 1982) .
Immunofluorescence. Muscle tissue was frozen in isopentane cooled in liquid nitrogen and stored at -7O'C. Cryosections (4-8 pm) were airdried and stored at -70%. Cell cultures were washed three times with PBS and stored at -70'C. After rehydration in PBS, sections and cultures were blocked with 1% bovine serum albumin or 10% normal goat serum and incubated for 16 hr at 4'C with anti-AMPda antisera (1:500). Bound antibodia were visualized by incubation for 1.5 hr at 22'C using fluoresceinconjugated goat anti-rabbit IgG (Sigma; St Louis. MO). Controls included omission of primary antibodies, substitution of immune serum by prcimmune serum, and incubation with immune sera of unrelated antigens.
To study co-localization of AMPda isoforms with neuromuscular junctions, double staining with tetramethylrhodamine-a-bungarotoxin (Molecular Probes; Eugene. OR), included in the secondary antibody solution. was carried out. a-Bungarotoxin binds specifically to acetylcholine recep-tors. which are largely concentrated at neuromuscular junctions. To determine the localization of AMPda isoforms with respect to muscle fiber types (i.e., Type I or Type 11) and with respect to myosin, double staining was performed with mouse anti-myosin fast (Sigma). This antibody was visualized using tctramcthylrhodaminc-conjugated goat anti-mousc IgG (Nordic; Tilburg. The Netherlands).
Immunofluorescence was studied on a Zciss Axioskop photomicroscope (Carl Zeiss; Oberkochen, Germany).
Results
AMPda M was localized predominantly in muscle fibers ( Figure  lA) , with greater immunoactivity near the sarcolemma (see also Figure 4B ). There was a strong preference for Type I1 (fast-twitch) fibers ( Figure 2A ). AMPda M displayed a cross-striation pattern (Figure 2A ). In unstretched (contracted) muscle, a major i"unofluorescent band was present over the I-band, making contact with the ends of the A-band. In more stretched fibers, this band was split into a doublet, the Z-line remaining unstained, and the two bands of the doublet being present at the boundary of the A-and I-band. In addition to the main band (doublet), a minor band was seen in the middle of the A-band (Figure 2A ). AMPda M was strongly concentrated at sites of neuromuscular junctions ( Figure 3A) and was co-localized with acetylcholine receptors (Figure 3D) . Capillary endothelial cells were also immunoreactive for AMPda M.
AMPda E was localized mainly in smooth muscle cells ( Figure  1B and 2B) . In muscle fibers, there was a preference for Type I (slowtwitch) fibers ( Figure 2B) . The E isoform showed a cross-striation pattern similar to the M isoform. Endothelial cells were also positive. Moderate immunoreactivity was seen in nerve bundles (Figure 1B) .
The major site of AMPda Lis within (myelinated) mons ( Figures  3B, and 3C ). Immunostaining continued into the nerve terminal. In contrast to the AMPda M isoform, there was no precise colocalization with acetylcholine receptor clusters ( Figures 3B, 3C , 3E. and 3F). This suggests that the L isoform is present at presynaptic sites rather than postsynaptic sites. Capillary endothelial cells and smooth muscle cells were moderately positive. No clear immunoreactivity was observed in muscle fibers.
AMP& in Patients with Primary Myoadenylate Deaminase Deficiency
Skeletal muscle tissue sections from four patients with primary AMPda deficiency (myoadenylate deaminase deficiency) were studied. They all lacked isoform M (Figure 4) . Isoforms L and E were not deficient (not shown).
AMP& in Cultured Human Muscle Cells
In mononuclear cells, including myoblasts, isoform L was present in the perinuclear area ( Figure SA) . The same was true for the E isoform, although to a lesser extent ( Figure 5B ). Both isoforms also gave some nuclear staining. Isoform M was not detectable in mononuclear cells ( Figure 5C ). In myotubes cultured with serumlchicken embryo extract, all three isoforms were present diffusely or as thread-like structures. In myotubes cultured with brain ex-tractlUltroser G, which results in a higher degree of maturation (Van Kuppevelt et al.. 1992; Benders et al., 1991) . the L and E isoforms were still present, diffusely or as thread-like structures, but the M isoform showed a clear cross-striation pattern (Figure 6 ).
Discussion
The three major isoforms of AMPda each show a characteristic distribution in human skeletal muscle, comparable with that observed for rat skeletal muscle (Thompson et al., 1992) . The main location of the M isoform is Type I1 muscle fibers, in agreement with the observation that the M isoform is more abundantly present in white muscle, i.e.. muscle with an abundance of Type I1 fibers (Tullson and Terjung, 1991). Electrophoretic and immunoprecipitation studies show that in human skeletal muscle AMPda M accounts for more than 95% of total AMPda (Fishbein et al., 1993; Mahnke-Zizelman and Sabina, 1991; Ogasawara et al.. 1982) . Northern blot analysis indicates a high level of expression of the AMPDl gene (coding for the M isoform) in skeletal muscle (Bausch-Jurken et al., 1992) . Being quantitatively the most important AMPda. the preference for Type I1 muscle fibers is consistent with slow-twitch fibers having a lower capacity for AMP deamination than fast-twitch fibers (Katz et al., 1986) .
Red but not white skeletal muscle of animals contains, in addi- tion to the M isoform, an appreciable amount of a second isoform similar to the isoform found in heart and erythrocytes. which corresponds to the E isoform in humans (Fishbein et al., 1993; Ogasawara et al., 1983) . On the basis of immunoprecipitation studies, it has been suggested that in human skeletal muscle a second AMPda isoform, probably the E isoform, is present (Fishbein et al., 1993) . This is substantiated by our study showing the E isoform in smooth muscle cells and in Type I (slow-twitch) skeletal muscle cells. It can be anticipated that the L isoform is quantita-tively only a minor component, since it is not present in the muscle fibers themselves. The L isoform is undetectable by biochemical means (Mahnke-Zizelman and Ogasawara et al., 1982) ; AMPda L mRNAs, however, have been demonstrated in small amounts in rat skeletal muscle, including diaphragm (Morisaki et al., 1990 ). An intriguing observation is the accumulation of isoform M at the postsynaptic site of the neuromuscular junction. The conversion of AMP to IMP by AMPda prevents degradation of AMP to adenosine and purine bases. Purine nucleosides and bases readily leave muscle tissue, whereas IMP remains within the cell. (Meyer and Terjung. 1980; Meyer et al., 1979; Jennings and Steenbergen, 1985) . Adenosine is a potent regulator of acetylcholine release at neuromuscular junctions (Brown et al., 1990) and may inhibit neuromuscular transmission (Ribeiro and Sebastiiio, 1987) . The amount of adenosine in the synapse should therefore be cardully controlled and the concentration of AMPda M at this site could be functional in this respect. Evidence that AMPda is indeed involved in the regulation of adenosine production stems from patients with AMPda deficiency who have elevated levels of adenosine in skeletal muscle after strenuous exercise (Sabina et al.. 1984) . A part of the AMPda M at the neuromuscular junction may be located extracellularly and may behave as an ectoenzyme. At the frog neuromuscular junction, IMP is produced extracellularly from AMP and extracellular ATP metabolism is present Sebastiiio, 1991,1993) . In addition, a considerable amount of 5'-nucleotidase, an enzyme competing for the same substrate (AMP) as AMPda, is acuacellular (&merman, 1992) . It has been suggested that at the neuromuscular junction, exuacetlular AMPda acts as a shunt-like mechanism, reducing the amount of adenosine formed from adenine nucleotides (Cunha and Sebastiiio, 1993) .
At the presynaptic site isoform Lis present, whereas at the postsynaptic site isoform M is present. These isoforms behave differently in many respects. In the presence of monovalent cations, the human isoforms M and El display hyperbolic kinetics with a K m for AMP of 0.6 mM, whereas isoform L displays sigmoid kinetics with a K m of 6.6 mM (Kaletha and Nowak, 1988; Ogasawara et al.. 1982) . This indicates that AMP binds more strongly to the M and El isoforms. ATP and GTP strongly affect the activity of isoform L but have only a slight effect on isoforms M and E. ADP strongly stimulates the M form but has little influence on the L type. Whether the presence of different isoforms is related to the different microenvironments (axon vs muscle cell with a more intense purine nucleotide metabolism) is unclear. The kinetics and modulation of AMPda are further complicated by alterations produced by binding to various sites in muscle tissue. The facile histoenzymatic identification of AMPda in muscle by a simple aqueous stain (Fishbein et al., 1980b) indicates that the enzyme is largely bound in unfixed tissue, and recent work suggests that its binding changes with activity and in tum affects the kinetic behavior of the enzyme (Rundell et al., 1990 (Rundell et al., ,1992a (Rundell et al., .b.1993 .
The AMPda M isoform is also located at the junction of the sarcomeric A-and I-bands. This is in agreement with studies on chicken and rat myofibers localizing AMPda to the ends of the A-band (Cooper and Trinick, 1984; Ashby et al., 1979) . AMPda binds to myosin. and this interaction has a strong influence on its reaction kinetics (Rundell et al., 1992a; Frieden, 1977,1978) . The binding of part of the main AMPda M-band to the I-band may be functional with respect to the ADP-binding properties of actin, ADP being the main stimulator of AMPda (Ronca-Testoni et al.. 1970) . Binding of AMPda to titin has also been reported (Koretz et al., 1993) .
In culture, the myoblasts are mainly immunoreactive with the E and L isoforms. where in the more differentiated myotubes isoform M is prominently present. This may reflect the shift from fetal isoforms, which have characteristics similar to the L isoform. to the M isoform during skeletal muscle development (Sabina et al., 1989; Kaletha and Nowak. 1988) . A shift in isoforms has been observed during differentiation of cultured human skeletal muscle cells Uacobs et al., 1992) . The AMPD2 gene, encoding for the L isoform. is expressed in embryonic muscle and undifferentiated rat Lb myoblasts, but is almost undetectable in adult skeletal muscle (Morisaki et al., 1990) . AMPda cross-striation has been observed in cultured skeletal muscle cells of chicken (Ashby et al., 1979) .
Congenital (primary) AMP-deaminase deficiency (myoadenylate deaminase deficiency) is a disorder characterized by muscle weakness, early fatigue, or cramping after exercise, and is caused by a mutation in the AMPDl gene (Morisaki et al., 1992) . It has been postulated that the remnant activity of AMPda in these patients is due to fetal isoforms (Jacobs et al., 1992; Kaletha and Nowak. 1988; Kaletha et al., 1987) and not to the M isoform (Fishbein and Armbrustmacher, 1984) . In patients, we found that AMPda M is absent, whereas isoform Land E are normally present. By immunoprecipitation, it has also been shown that a considerable amount of the remaining AMPda ream with anti-E isoform antibodies (Fishbein et al.. 1993; Mahnke-Zizelman and Sabina, 1992) . Northern blot analysis indicates no decrease in the amount of E-isoform transcripts in patients (Mahnke-Zizelman and . The activity of AMPda in erythrocytes (the E isoform) is also not affected (Fishbein et al.. 1980a) .
In summary, the AMPda isoforms M. L, and E each have a characteristic distribution in human skeletal muscle, which is in agreement with biochemical and molecular biological data. The presence of AMPda at the neuromuscular junction may be important in the regulation of adenosine levels in the synaptic cleft.
